M&A Deal Summary

Ivy Capital Partners Acquires Stanmore Implants Worldwide

On September 30, 2008, private equity firm Ivy Capital Partners acquired medical products company Stanmore Implants Worldwide for 12M GBP

Acquisition Highlights
  • This is Ivy Capital Partners’ 6th transaction in the Medical Products sector.
  • This is Ivy Capital Partners’ 0th largest (disclosed) transaction.
  • This is Ivy Capital Partners’ 1st transaction in the United Kingdom.
Investment Fate
  • Stanmore Implants Worldwide was sold to a strategic buyer in 2016 for 36M GBP.

M&A Deal Summary

Date 2008-09-30
Target Stanmore Implants Worldwide
Sector Medical Products
Buyer(s) Ivy Capital Partners
Deal Type Buyout (LBO, MBO, MBI)
Deal Value 12M GBP

Target

Stanmore Implants Worldwide

Stanmore, United Kingdom
website
Stanmore Implants Worldwide Ltd. is an orthopedic company focused on saving and restoring the function of limbs and joints. The Company provides patient-specific and standardized orthopedic implants for limb salvage, complex joint replacements and prosthetic attachment.

Search 175,694 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Ivy Capital Partners

Montvale, New Jersey, United States

website


Category Private Equity Firm
Founded 2002
SizeSmall
Type Sector Focused
DESCRIPTION

Ivy Capital Partners is a specialized private equity firm that seeks investments in companies that operate in the musculoeskeletal sector of the healthcare industry. Specific areas of interest within the musculoskeletal sector include sports medicine, joint implants, rehabilitation products and services, trauma, spine and therapeutics. The Firm will consider both mid to later stage investment situations. Ivy Capital Partners is a unit of investment firm Ivy Equities and is based in Montvale, New Jersey.


DEAL STATS #
Overall 9 of 12
Sector (Medical Products) 6 of 9
Type (Buyout (LBO, MBO, MBI)) 3 of 3
Country (United Kingdom) 1 of 1
Year (2008) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-07-04 ReGen Biologics

Hackensack, New Jersey, United States

ReGen Biologics, Inc. is a publicly traded orthopedics products company that has developed a collagen matrix technology for use in a variety of medical applications.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-10-29 MAKO Surgical

Ft. Lauderdale, Florida, United States

MAKO provides an advanced robotic solution and orthopedic implants for minimally invasive orthopedic knee procedures. MAKO's proprietary cleared, FDA robotic surgery system offers surgeons patient-specific visualization and the tools to safely treat early to mid-stage osteoarthritic knee disease in a reproducible manner.

Sell -